Centre Hospitalier Universitaire De Bordeaux

The department of Internal Medicine and Infectious Diseases at Centre Hospitalier Universitaire De Bordeaux is conducting research on Systemic lupus erythematosus to improve treatment outcomes. A trial evaluates the effectiveness of the biologic agent anifrolumab in patients who have not previously received immunosuppressants or biologics.

• Evaluation of anifrolumab in treatment‑naïve systemic lupus erythematosus
• Assessment of DORIS remission criteria in SLE patients
• Glucocorticoid‑sparing strategies for autoimmune disease management

The goal is to achieve DORIS remission while minimizing exposure to glucocorticoids, providing clearer guidance for clinicians and hope for patients.

Research at Centre Hospitalier Universitaire De Bordeaux explores advanced imaging for cholangiocarcinoma. A separate study assesses the value of 68Ga-FAPI-46 PET-CT in the initial staging of pancreatic and biliary cancers.

• Use of 68Ga-FAPI-46 PET-CT for initial cancer staging
• Comparison of imaging modalities in pancreatic and bile duct tumors
• Evaluation of TNM classification changes after advanced PET imaging

The aim is to determine how often the imaging alters the TNM classification, potentially guiding curative treatment decisions for patients.